Meters & Monitors

Blood Glucose Meters Current Continuous Monitors Comparison of Available Monitors
Various Future Monitors Improving Today's Meters Other Monitors Older Monitors

Future Monitoring

AiMedics A.Menarini Diagnostics Cybiocare OHD Fovioptics InLight Solutions Kumetrix LighTouch Medical NAS - iSense NIR Diagnostics Optiscan Pindi Products Sensors For Medicine and Science Sensys Medical Sentek Solianis Sontra SpectRx Synthetic Blood International Therasense Visual Pathways

Key

	Non-Invasive
	Semi-Invasive
	Surgical
	Continuous

Fovioptics

Fovioptics, based in Lexington, Kentucky, is developing the Retinal Blood Analyzer (RBA), a non-invasive blood diagnostic system.  The RBA uses the Company's patent-protected data analysis processes, combined with existing retinal camera technology, to measure important blood components and other critical care metrics using the human body's natural window to the blood: the eye.  This breakthrough technology platform solves the inherent problems that have plagued competing non-invasive diagnostic efforts and offers significant advantages over traditional needle-based systems, including cost, patient comfort, repeatability, and infection control. The RBA has the potential to provide immediate, real-time measurements for a variety of applications previously attainable only through blood sampling or other invasive means.

For information concerning Fovioptics, please contact

Mark J. Rice, MD, President
1509 Bull Lea Drive, Suite 300
Lexington, KY  40511
859-255-2606 x222
MarkBRM@aol.com